# LANREOTIDE ACETATE
> **NDA215395** · New Drug Application · Sponsor: INVAGEN PHARMS · Approved 2021-12-17
## Drug
- **FDA Application Number:** NDA215395
- **Application type:** New Drug Application
- **Brand name:** LANREOTIDE ACETATE
- **Generic name:** LANREOTIDE ACETATE
- **Active ingredients:** LANREOTIDE ACETATE
- **Dosage form:** SOLUTION
- **Route:** SUBCUTANEOUS
- **Marketing status:** Prescription
- **Sponsor:** INVAGEN PHARMS
- **Manufacturer:** Cipla USA Inc.
- **First approval:** 2021-12-17
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=215395)
---
*MORVS · CC0 1.0*